Literature DB >> 313227

Evidence from behavioural reactions to fenfluramine, 5-hydroxytryptophan, and 5-methoxy-N,N-dimethyltryptamine for differential effects of short-term and long-term lithium on indoleaminergic mechanisms in rats [proceedings].

P E Harrison-Read.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 313227      PMCID： PMC2043809     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  4 in total

1.  Lithium-induced hypersensitivity to foot shock in rats and the role of 5-hydroxytryptophan.

Authors:  P E Harrison-Read; H Steinberg
Journal:  Nat New Biol       Date:  1971-07-28

Review 2.  An animal behavior model for studying central serotonergic synapses.

Authors:  B L Jacobs
Journal:  Life Sci       Date:  1976-09-15       Impact factor: 5.037

3.  The role of noradrenaline, dopamine and 5-hydroxytryptamine in the hyperactivity response resulting from the administration of tranylcypramine to rats pretreated with lithium or rubidium.

Authors:  A Judd; J Parker; F A Jenner
Journal:  Psychopharmacologia       Date:  1975-04-30

4.  The effect of lithium on the increase in forebrain 5-hydroxyindoleacetic acid produced by raphe stimulation.

Authors:  K J Collard
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739
  4 in total
  3 in total

Review 1.  Lithium and serotonin function: implications for the serotonin hypothesis of depression.

Authors:  L H Price; D S Charney; P L Delgado; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man.

Authors:  H D Mühlbauer; B Müller-Oerlinghausen
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

Review 3.  A narrative synthesis of research with 5-MeO-DMT.

Authors:  Anna O Ermakova; Fiona Dunbar; James Rucker; Matthew W Johnson
Journal:  J Psychopharmacol       Date:  2021-10-19       Impact factor: 4.153
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.